Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $151.40
  • Support level
    $128.33
  • Resistance level
    N/A
  • Beta
    0.3
  • RSI (14-day)
    63.0
  • GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
  • GILD is one of this month's top performers with a return of 15.4 percent, beating 90 percent of stocks in the S&P-100.
  • Volatility is forecast to fall over the next month.
  • Price broke above prior resistance level - a short-term bullish signal.

52-week range

52-week low 52-week high Price as % of range
$96.91 $155.80 94.0%

Moving averages

200 day 50 day 20 day 10 day
$118.92 $132.58 $147.11 $152.45

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    7.9%
  • In the next month
    15.7%
  • In the next year
    55.9%

Volatility estimates (annualized standard deviations)

Period Value
Historical (5 year) 23.9%
Last month 26.3%
Current estimate 28.9%
Next month forecast 27.8%